These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33430830)

  • 1. Regional brain volume predicts response to methylphenidate treatment in individuals with ADHD.
    Chang JC; Lin HY; Lv J; Tseng WI; Gau SS
    BMC Psychiatry; 2021 Jan; 21(1):26. PubMed ID: 33430830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment effect of methylphenidate on intrinsic functional brain network in medication-naïve ADHD children: A multivariate analysis.
    Yoo JH; Kim D; Choi J; Jeong B
    Brain Imaging Behav; 2018 Apr; 12(2):518-531. PubMed ID: 28417219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time and psychostimulants: Opposing long-term structural effects in the adult ADHD brain. A longitudinal MR study.
    Pretus C; Ramos-Quiroga JA; Richarte V; Corrales M; Picado M; Carmona S; Vilarroya Ó
    Eur Neuropsychopharmacol; 2017 Dec; 27(12):1238-1247. PubMed ID: 29129558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcortical volumetric alterations as potential predictors of methylphenidate treatment response in youth with attention-deficit/hyperactivity disorder.
    Kim JS; Lee KH; Hwang CS; Kim JW
    J Psychiatry Neurosci; 2022; 47(1):E11-E20. PubMed ID: 35027444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striatal volume deficits in children with ADHD who present a poor response to methylphenidate.
    Moreno A; Duñó L; Hoekzema E; Picado M; Martín LM; Fauquet J; Vives-Gilabert Y; Bulbena A; Vilarroya O
    Eur Child Adolesc Psychiatry; 2014 Sep; 23(9):805-12. PubMed ID: 24395136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grey matter volumes in treatment naïve vs. chronically treated children with attention deficit/hyperactivity disorder: a combined approach.
    Villemonteix T; De Brito SA; Kavec M; Balériaux D; Metens T; Slama H; Baijot S; Mary A; Peigneux P; Massat I
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1118-27. PubMed ID: 25934396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional brain network organization distinguishes the combined and inattentive subtypes of Attention Deficit Hyperactivity Disorder.
    Saad JF; Griffiths KR; Kohn MR; Clarke S; Williams LM; Korgaonkar MS
    Neuroimage Clin; 2017; 15():383-390. PubMed ID: 28580295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting Methylphenidate Response in ADHD Using Machine Learning Approaches.
    Kim JW; Sharma V; Ryan ND
    Int J Neuropsychopharmacol; 2015 May; 18(11):pyv052. PubMed ID: 25964505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of methylphenidate intake on brain structure in adults with ADHD in a placebo-controlled randomized trial.
    Tebartz van Elst L; Maier S; Klöppel S; Graf E; Killius C; Rump M; Sobanski E; Ebert D; Berger M; Warnke A; Matthies S; Perlov E; Philipsen A
    J Psychiatry Neurosci; 2016 Oct; 41(6):422-430. PubMed ID: 27575717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between regional cerebral blood flow and response to methylphenidate in children with attention-deficit hyperactivity disorder: comparison between non-responders to methylphenidate and responders.
    Cho SC; Hwang JW; Kim BN; Lee HY; Kim HW; Lee JS; Shin MS; Lee DS
    J Psychiatr Res; 2007 Sep; 41(6):459-65. PubMed ID: 16839567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of methylphenidate and atomoxetine on intrinsic brain activity in children with attention deficit hyperactivity disorder.
    Shang CY; Yan CG; Lin HY; Tseng WY; Castellanos FX; Gau SS
    Psychol Med; 2016 Nov; 46(15):3173-3185. PubMed ID: 27574878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
    Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH
    Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global and regional gray matter reductions in ADHD: a voxel-based morphometric study.
    Carmona S; Vilarroya O; Bielsa A; Trèmols V; Soliva JC; Rovira M; Tomàs J; Raheb C; Gispert JD; Batlle S; Bulbena A
    Neurosci Lett; 2005 Dec; 389(2):88-93. PubMed ID: 16129560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic imaging study with [Tc-
    Akay AP; Kaya GÇ; Kose S; Yazıcıoğlu ÇE; Erkuran HÖ; Güney SA; Oğuz K; Keskin D; Baykara B; Emiroğlu Nİ; Eren MŞ; Kızıldağ S; Ertay T; Özsoylu D; Miral S; Durak H; Gönül AS; Rohde LA
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():294-300. PubMed ID: 29684537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR imaging of the effects of methylphenidate on brain structure and function in attention-deficit/hyperactivity disorder.
    Schweren LJ; de Zeeuw P; Durston S
    Eur Neuropsychopharmacol; 2013 Oct; 23(10):1151-64. PubMed ID: 23165220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulant treatment history predicts frontal-striatal structural connectivity in adolescents with attention-deficit/hyperactivity disorder.
    Schweren LJ; Hartman CA; Zwiers MP; Heslenfeld DJ; Franke B; Oosterlaan J; Buitelaar JK; Hoekstra PJ
    Eur Neuropsychopharmacol; 2016 Apr; 26(4):674-83. PubMed ID: 26899587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulant drugs trigger transient volumetric changes in the human ventral striatum.
    Hoekzema E; Carmona S; Ramos-Quiroga JA; Canals C; Moreno A; Richarte Fernández V; Picado M; Bosch R; Duñó L; Soliva JC; Rovira M; Bulbena A; Tobeña A; Casas M; Vilarroya O
    Brain Struct Funct; 2014 Jan; 219(1):23-34. PubMed ID: 23184398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined stimulant and antipsychotic treatment in adolescents with attention-deficit/hyperactivity disorder: a cross-sectional observational structural MRI study.
    Schweren LJ; Hartman CA; Zwiers MP; Heslenfeld DJ; van der Meer D; Franke B; Oosterlaan J; Buitelaar JK; Hoekstra PJ
    Eur Child Adolesc Psychiatry; 2015 Aug; 24(8):959-68. PubMed ID: 25395383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence.
    Crunelle CL; van den Brink W; Veltman DJ; van Emmerik-van Oortmerssen K; Dom G; Schoevers RA; Booij J
    Eur Neuropsychopharmacol; 2013 Dec; 23(12):1714-23. PubMed ID: 23731497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmentally stable whole-brain volume reductions and developmentally sensitive caudate and putamen volume alterations in those with attention-deficit/hyperactivity disorder and their unaffected siblings.
    Greven CU; Bralten J; Mennes M; O'Dwyer L; van Hulzen KJ; Rommelse N; Schweren LJ; Hoekstra PJ; Hartman CA; Heslenfeld D; Oosterlaan J; Faraone SV; Franke B; Zwiers MP; Arias-Vasquez A; Buitelaar JK
    JAMA Psychiatry; 2015 May; 72(5):490-9. PubMed ID: 25785435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.